CRYOPORT, INC. Number of Reporting Units
CRYOPORT, INC. (CYRX) reported Number of Reporting Units of 1 segment for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes
us-gaap:NumberOfReportingUnits · last filed 2024-11-07
- CRYOPORT, INC. number of reporting units for the quarter ending 2024-03-31 was 1.00 segment, a 0.00% change year-over-year.
- CRYOPORT, INC. number of reporting units for the quarter ending 2023-03-31 was 1.00 segment.
| Period end | Number of Reporting Units 3 month | Number of Reporting Units 6 month | Number of Reporting Units 9 month |
|---|---|---|---|
| 2024-09-30 | 1.00 segment 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | 1.00 segment 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | 1.00 segment 10-Q · filed 2024-05-08 | ||
| 2023-09-30 | 1.00 segment 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | 1.00 segment 10-Q · filed 2023-08-09 | ||
| 2023-03-31 | 1.00 segment 10-Q · filed 2023-05-04 | ||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-11-04 | ||
| 2022-06-30 | 1.00 segment 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |